Medicine & Health

Some Source stories from years past continue to attract new readers. Here, we check in with WashU researchers in linguistics, psychology, engineering and other disciplines to learn more about their work and how the research has progressed.

Three WashU researchers developing promising therapeutics for cancer and heart disease are the inaugural awardees of the Needleman Program for Innovation and Commercialization. The next round of project proposals is now open.

Todd A. Fehniger, MD, PhD, and colleagues Alice Y. Zhou, MD, PhD, Ryan C. Fields, MD, and George Ansstas, MD, all at the School of Medicine, have received $1.5 million from the Rising Tide Foundation for Cancer Research and the Melanoma Research Alliance.

A new study from the School of Medicine identifies a key feedback loop between the brain and the fat tissue that governs aging in mice. The research suggests that the loop’s gradual deterioration contributes to health problems typical of aging.

States that emphasized non-pharmaceutical interventions, such as distancing and mask wearing, fared better in curbing the spread of COVID-19, shows a forthcoming study from the Brown School.

Sleep helps restore the brain’s operating system to a critical state, according to new findings from biology and physics researchers in Arts & Sciences.

Researchers at the School of Medicine found that metabolism-boosting, bile acid-reducing drugs improved gut health in mice. The findings indicate a new approach that may help malnourished children with stunted growth.

Researchers at the School of Medicine have determined how Eastern equine encephalitis virus attaches to a receptor it uses to enter and infect cells. The findings lay a foundation for treatments and vaccines for viral infections.

Gary Weil, MD, a professor of medicine and of molecular microbiology at the School of Medicine, received the 2023 Kyelem Prize at the Coalition for Operational Research on Neglected Tropical Diseases’ annual meeting.

Todd A. Fehniger, MD, PhD, and co-principal investigators Jeffrey J. Bednarski, MD, PhD, and Thomas Pfeiffer, MD, all at the School of Medicine, have received a total of $1.4 million from the Leukemia & Lymphoma Society, the Rising Tide Foundation for Clinical Cancer Research and Siteman Kids to support a clinical trial of a novel cell-based immunotherapy.